Mucosal Delivery of a Pneumococcal Vaccine Using Lactococcus lactis Affords Protection against Respiratory Infection
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Economical and effective vaccines against Streptococcus pneumoniae (pneumococcus) are needed for implementation in poorer countries where the disease burden is highest. Here, we evaluated Lactococcus lactis intracellularly producing the pneumococcal surface protein A (PspA) as a mucosal vaccine in conferring protection against pneumococcal disease. METHODS: Mice were intranasally (inl) immunized with the lactococcal vaccine. Control groups were also immunized with similar amounts of recombinant PspA administered inl or subcutaneously with alum. PspA-specific antibodies in serum samples and lung lavage fluids were measured before challenge in intraperitoneal sepsis and inl respiratory-infection models of pneumococcal disease. RESULTS: The lactococcal vaccine afforded better protection against respiratory challenge with pneumococcus than did vaccination with purified antigen given inl or by injection with alum. This finding was associated with a shift toward a Th1-mediated immune response characterized by reduced antibody titers to the PspA antigen. In the sepsis model, the lactococcal vaccine afforded resistance to disease on a par with that obtained with the injected vaccine, demonstrating its efficacy against different forms of pneumococcal disease. CONCLUSION: Given the safety profile of L. lactis, there is considerable potential to develop a pneumococcal vaccine for use in humans and to broaden this approach to combat other major pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Streptococcus pneumoniae colonisation: the key to pneumococcal disease
Bogaert, D., de Groot, R., & Hermans, P. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)00938-7 · Cited by 1,929 · cited 4×
“Many pneumococcal strains (notably serotypes 2-6) are virulent in mice, causing fatal sepsis when administered intravenously or intraperitoneally (ip) [7].”
BackgroundInfluentialCD4 + T cells mediate antibody-independent acquired immunity to pneumococcal colonization
Malley, R., Trzcinski, K., Srivastava, A., Thompson, C. M., Anderson, P. W., & Lipsitch, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501254102 · Cited by 346 · cited 1×
“More recently, experiments performed in antibody-deficient MuMT-/- mice and using live pneumococcal-based or killed nonencapsulated whole cell vaccines demonstrated that long-term immunity to pneumococcal colon zation could be acquired in the absence of antibody via a CD4' T cell-dependent mechanism [51].”
BackgroundThe Immune Response to Pneumococcal Proteins during Experimental Human Carriage
McCool, T. L., Cate, T. R., Moy, G., & Weiser, J. N. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011576 · Cited by 270 · cited 1×
“Humans naturally infected or colonized with pneumococcus develop anti-PspA antibodies in both serum and mucosal secretions, with antibody to the a-helical domain of PspA also implicated in preventing pneumococcal carriage [24].”
Background
Cited by
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria
Wells, J. M., & Mercenier, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1840 · Cited by 537
Self-citationPettigrew, M. M., Laufer, A. S., Gent, J. F., Kong, Y., Fennie, K. P., & Metlay, J. P. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.01051-12 · Cited by 183
Oxaran, V., Ledue-Clier, F., Dieye, Y., Herry, J.-M., Péchoux, C., Meylheuc, T., Briandet, R., Juillard, V., & Piard, J.-C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050989 · Cited by 73
“[2,3,4,5,6,7], enzymes or vitamins for improved health status of consumers [8], antimicrobials for improved food safety [9], and”
Background
Metadata
- Authors
- Hanniffy, S. B., Carter, A. T., Hitchin, E., & Wells, J. M.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-01-15
- Volume
- 195
- Issue
- 2
- Pages
- 185-193
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2096776587
- Cited by
- 104
- References
- 3
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mucosal Delivery of a Pneumococcal Vaccine Using Lactococcus lactis Affords Protection against Respiratory Infection. https://app.cochat.ai/papers/10.1086/509807
- The paper
- Hanniffy, S. B., Carter, A. T., Hitchin, E., & Wells, J. M. (2007). Mucosal Delivery of a Pneumococcal Vaccine Using Lactococcus lactis Affords Protection against Respiratory Infection. The Journal of Infectious Diseases. https://doi.org/10.1086/509807
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.